Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:26:01.738Z.
Calculation as of: 2026-10-06T14:26:01.738Z.
Quote observation: 2026-10-06T14:25:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3328ed161ff00c537a80d7dceb604f662f1c22c4e65cb57a824bf36ce3bbbe60
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Corvus Pharmaceuticals, Inc.
Market Cap
$865.29M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$882.16M
Free Cash Flow Yield
N/A
TTM Avg
16.58%
3Y Avg
25.91%
5Y Avg
25.91%
Market Cap
$843.53M
Free Cash Flow Yield
N/A
TTM Avg
10.05%
3Y Avg
10.05%
5Y Avg
10.05%
Market Cap
$890.64M
Free Cash Flow Yield
10.59%
TTM Avg
10.89%
3Y Avg
6.48%
5Y Avg
5.13%
Market Cap
$817.92M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$917.50M
Free Cash Flow Yield
5.32%
TTM Avg
7.65%
3Y Avg
6.69%
5Y Avg
6.16%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $865.29M | N/A | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $882.16M | N/A | 16.58% | 25.91% | 25.91% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $843.53M | N/A | 10.05% | 10.05% | 10.05% |
| Bioventus Inc. (BVS)vs › | $890.64M | 10.59% | 10.89% | 6.48% | 5.13% |
| Beta Bionics, Inc. (BBNX)vs › | $835.01M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $825.62M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $818.83M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $817.92M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $917.50M | 5.32% | 7.65% | 6.69% | 6.16% |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | N/A | 24.40% | 22.30% | 22.30% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
